←Back to Expert Scholars
Translational Medicine / 转化医学AML Novel Targets, Elderly AML
Gerwin Huls
MD, PhD
🏢University Medical Center Groningen🌐Netherlands
Professor of Hematology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Gerwin Huls leads AML trials through the Dutch HOVON cooperative group at Groningen. He has led studies of lenalidomide maintenance and azacitidine-based approaches in elderly AML. His work informs European AML standards for older patients.
Share:
🧪Research Fields 研究领域
AML elderly
HOVON trials
azacitidine
Dutch AML research
lenalidomide AML
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Gerwin Huls 的研究动态
Follow Gerwin Huls's research updates
留下邮箱，当我们发布与 Gerwin Huls（University Medical Center Groningen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment